Airsculpt Technologies Inc (AIRS)vsThe Ensign Group Inc (ENSG)
AIRS
Airsculpt Technologies Inc
$1.73
+3.59%
HEALTHCARE · Cap: $124.72M
ENSG
The Ensign Group Inc
$181.52
-2.58%
HEALTHCARE · Cap: $10.73B
Smart Verdict
WallStSmart Research — data-driven comparison
The Ensign Group Inc generates 3540% more annual revenue ($5.49B vs $150.72M). ENSG leads profitability with a 6.9% profit margin vs -7.8%. ENSG earns a higher WallStSmart Score of 62/100 (C+).
AIRS
Hold41
out of 100
Grade: D
ENSG
Buy62
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+32.9%
Fair Value
$3.16
Current Price
$1.73
$1.43 discount
Margin of Safety
-39.9%
Fair Value
$151.53
Current Price
$181.52
$29.99 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Earnings expanding 200.0% YoY
17.3% revenue growth
Areas to Watch
Smaller company, higher risk/reward
Weak financial health signals
ROE of -11.2% — below average capital efficiency
Revenue declined 2.5%
Moderate valuation
6.9% margin — thin
Comparative Analysis Report
WallStSmart ResearchBull Case : AIRS
The strongest argument for AIRS centers on Price/Book, EPS Growth.
Bull Case : ENSG
The strongest argument for ENSG centers on Revenue Growth. Revenue growth of 17.3% demonstrates continued momentum. PEG of 1.34 suggests the stock is reasonably priced for its growth.
Bear Case : AIRS
The primary concerns for AIRS are Market Cap, Piotroski F-Score, Return on Equity.
Bear Case : ENSG
The primary concerns for ENSG are P/E Ratio, Profit Margin.
Key Dynamics to Monitor
AIRS profiles as a turnaround stock while ENSG is a growth play — different risk/reward profiles.
AIRS carries more volatility with a beta of 2.33 — expect wider price swings.
ENSG is growing revenue faster at 17.3% — sustainability is the question.
ENSG generates stronger free cash flow (119M), providing more financial flexibility.
Bottom Line
ENSG scores higher overall (62/100 vs 41/100) and 17.3% revenue growth. AIRS offers better value entry with a 32.9% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Airsculpt Technologies Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Airsculpt Technologies Inc (AIRS) is at the forefront of the aesthetic medical technology sector, specializing in its proprietary AirSculpt® procedure, which sets a new standard for minimally invasive body contouring while prioritizing patient safety and comfort. The company is aggressively expanding its network of licensed practitioners and utilizing innovative technologies to solidify its competitive advantage in the rapidly growing non-invasive cosmetic treatment market. With rising global demand for aesthetic solutions, Airsculpt is well-positioned to capture market share and broaden its service offerings, driving robust growth and long-term value for its investors.
Visit Website →The Ensign Group Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company is headquartered in San Juan Capistrano, California.
Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?